TY - JOUR
T1 - Identifying solutions to psychological insulin resistance
T2 - An international study
AU - Polonsky, William H.
AU - Fisher, Lawrence
AU - Hessler, Danielle
AU - Stuckey, Heather
AU - Snoek, Frank J.
AU - Tang, Tricia
AU - Hermanns, Norbert
AU - Mundet, Xavier
AU - Silva, Maria
AU - Sturt, Jackie
AU - Okazaki, Kentaro
AU - Hadjiyianni, Irene
AU - Cao, Dachuang
AU - Ivanova, Jasmina
AU - Desai, Urvi
AU - Perez-Nieves, Magaly
N1 - Funding Information:
This study was sponsored by Eli Lilly and Company .
Funding Information:
Conflict of interest: WHP has served as a consultant for Eli Lilly, Novo Nordisk, Sanofi, Astra Zeneca, Dexcom, Intarcia, Merck and Mannkind. LF has served as a consultant for Eli Lilly and Abbott Diabetes Care. JS has served as a consultant for Eli Lilly and Spirit Healthcare. NH reports grants and personal fees from Abbott, Berlin Chemie, Ypsomed, Lilly, Dexcom and Roche. FJS has served as consultant for Eli Lilly, Sanofi and Roche, and has received research funding from Sanofi. KO, MS, XM, and HS have served as consultants for Eli Lilly. DC, IH, and MPN are employees of Eli Lilly and Company. UD is an employee of Analysis Group, Inc., a company that received funding for this research from Eli Lilly and C9ompany. JI was an employee of Analysis Group, Inc. at the time of the study.
Publisher Copyright:
© 2019 The Authors
PY - 2019/4
Y1 - 2019/4
N2 - Aims: To identify actions of healthcare professionals (HCPs) that facilitate the transition to insulin therapy (IT) in type 2 diabetes (T2D) adults. Methods: Included were T2Ds in seven countries (n = 594) who reported initial IT reluctance but eventually began IT. An online survey included 38 possible HCP actions: T2Ds indicated which may have occurred and their helpfulness. Also reported were delays in IT start after initial recommendation and any period of IT discontinuation. Results: Exploratory factor analysis of HCP actions yielded five factors: “Explained Insulin Benefits” (EIB), “Dispelled Insulin Myths” (DIM), “Demonstrated the Injection Process” (DIP), “Collaborative Style” (CS) and “Authoritarian Style” (AS). Highest levels of helpfulness occurred for DIP, EIB and CS; lowest for AS. Participants who rated DIP as helpful were less likely to delay IT than those who rated DIP as less helpful (OR = 0.75, p = 0.01); participants who rated CS and EIB as helpful were less likely to interrupt IT than those who rated these as less helpful (OR = 0.55, p < 0.01; OR = 0.51, p = 0.01, respectively). Conclusions: Three key HCP actions to facilitate IT initiation were identified as helpful and were associated with more successful initiation and persistence. These findings may aid the development of interventions to address reluctance to initiating IT.
AB - Aims: To identify actions of healthcare professionals (HCPs) that facilitate the transition to insulin therapy (IT) in type 2 diabetes (T2D) adults. Methods: Included were T2Ds in seven countries (n = 594) who reported initial IT reluctance but eventually began IT. An online survey included 38 possible HCP actions: T2Ds indicated which may have occurred and their helpfulness. Also reported were delays in IT start after initial recommendation and any period of IT discontinuation. Results: Exploratory factor analysis of HCP actions yielded five factors: “Explained Insulin Benefits” (EIB), “Dispelled Insulin Myths” (DIM), “Demonstrated the Injection Process” (DIP), “Collaborative Style” (CS) and “Authoritarian Style” (AS). Highest levels of helpfulness occurred for DIP, EIB and CS; lowest for AS. Participants who rated DIP as helpful were less likely to delay IT than those who rated DIP as less helpful (OR = 0.75, p = 0.01); participants who rated CS and EIB as helpful were less likely to interrupt IT than those who rated these as less helpful (OR = 0.55, p < 0.01; OR = 0.51, p = 0.01, respectively). Conclusions: Three key HCP actions to facilitate IT initiation were identified as helpful and were associated with more successful initiation and persistence. These findings may aid the development of interventions to address reluctance to initiating IT.
UR - http://www.scopus.com/inward/record.url?scp=85060703707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060703707&partnerID=8YFLogxK
U2 - 10.1016/j.jdiacomp.2019.01.001
DO - 10.1016/j.jdiacomp.2019.01.001
M3 - Article
C2 - 30709604
AN - SCOPUS:85060703707
SN - 1056-8727
VL - 33
SP - 307
EP - 314
JO - Journal of Diabetes and its Complications
JF - Journal of Diabetes and its Complications
IS - 4
ER -